Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: Mar 21, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed an 8-K on March 19th, covering various disclosures and events.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on March 21, 2024, reporting events that occurred on March 19, 2024. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Atrinsic, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This 8-K filing provides updates on company events and disclosures, which are important for investors to stay informed about the latest developments at Protagenic Therapeutics.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant negative or positive news that would immediately impact the company's risk profile.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- March 19, 2024 (date) — Earliest event reported
- March 21, 2024 (date) — Filing date
- Atrinsic, Inc. (company) — Former company name
FAQ
What specific events are disclosed in this 8-K filing?
The filing indicates disclosures related to Regulation FD, Other Events, and Financial Statements and Exhibits, but the specific details of these events are not provided in the provided text.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 19, 2024.
What is the filing date of this 8-K?
This 8-K was filed on March 21, 2024.
What was Protagenic Therapeutics, Inc. formerly known as?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc.
In which state is Protagenic Therapeutics, Inc. incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-03-21 08:50:38
Key Financial Figures
- $1.00 — the Company's common stock of at least $1.00 per share for the last ten consecutive
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex99-1.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-010741.txt ( ) — 277KB
- ptix-20240319.xsd (EX-101.SCH) — 4KB
- ptix-20240319_def.xml (EX-101.DEF) — 26KB
- ptix-20240319_lab.xml (EX-101.LAB) — 36KB
- ptix-20240319_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: March 21, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3